Literature DB >> 14696816

A road less travelled by. A review lecture given to the Royal Irish Academy on the occasion of the Award of Merit and Silver Medal by the Consultative Committee for Pharmacology & Toxicology on 22 November 2001.

David J King1.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14696816      PMCID： PMC2475430     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN： 0041-6193


× No keyword cloud information.
  20 in total

Review 1.  ON THE DISSIMILAR EFFECTS OF DRUGS ON THE DIGIT SYMBOL SUBSTITUTION AND CONTINOUS PERFORMANCE TESTS. A REVIEW AND PRELIMINARY INTEGRATION OF BEHAVIORAL AND PHYSIOLOGICAL EVIDENCE.

Authors:  A F MIRSKY; C KORNETSKY
Journal:  Psychopharmacologia       Date:  1964-02-12

2.  PD-135,158, a cholecystokinin(B) antagonist, enhances latent inhibition in the rat.

Authors:  D J Gracey; R Bell; D J King
Journal:  Pharmacol Biochem Behav       Date:  2000-03       Impact factor: 3.533

3.  The clinical correlates of neurological soft signs in chronic schizophrenia.

Authors:  D J King; A Wilson; S J Cooper; J L Waddington
Journal:  Br J Psychiatry       Date:  1991-06       Impact factor: 9.319

4.  A placebo controlled trial of remoxipride in the prevention of relapse in chronic schizophrenia.

Authors:  D J King; M Blomqvist; S J Cooper; M M Doherty; M J Mitchell; R C Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Antipsychotic drug-induced dysphoria.

Authors:  D J King; M Burke; R A Lucas
Journal:  Br J Psychiatry       Date:  1995-10       Impact factor: 9.319

Review 6.  The effect of neuroleptics on cognitive and psychomotor function.

Authors:  D J King
Journal:  Br J Psychiatry       Date:  1990-12       Impact factor: 9.319

7.  Psychotropic drug use in Northern Ireland 1966-80: prescribing trends, inter- and intra-regional comparisons and relationship to demographic and socioeconomic variables.

Authors:  D J King; K Griffiths; P M Reilly; J D Merrett
Journal:  Psychol Med       Date:  1982-11       Impact factor: 7.723

8.  The effect of electroconvulsive therapy on CSF amine metabolites in schizophrenic patients.

Authors:  S J Cooper; W Leahey; D F Green; D J King
Journal:  Br J Psychiatry       Date:  1988-01       Impact factor: 9.319

9.  Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo.

Authors:  M Peet; M S Bethell; A Coates; A K Khamnee; P Hall; S J Cooper; D J King; R A Yates
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319

10.  Propranolol in schizophrenia. II. Clinical and biochemical aspects of combining propranolol with chlorpromazine.

Authors:  M Peet; D N Middlemiss; R A Yates
Journal:  Br J Psychiatry       Date:  1981-08       Impact factor: 9.319
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.